Cytek Biosciences (CTKB) Income from Non-Controlling Interests (2021 - 2023)
Cytek Biosciences posted quarterly Income from Non-Controlling Interests of -$235000.0 for Q1 2023, down 71.53% year-on-year from -$825512.8 in Q1 2022, and down 224.34% on a QoQ basis from $189000.0 in Q4 2022.
Cytek Biosciences (CTKB) has 3 years of Income from Non-Controlling Interests data on file, last reported at -$235000.0 in Q1 2023.
- For the quarter ending Q1 2023, Income from Non-Controlling Interests fell 71.53% year-over-year to -$235000.0; the trailing twelve-month figure through Dec 2023 stood at -$46000.0 (down 139.66% YoY), and the FY2022 full-year result was -$92000.0, down 453.85% from the prior year.
- Income from Non-Controlling Interests for Q1 2023 stood at -$235000.0, down from $189000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $315000.0 in Q1 2021 and bottomed at -$315000.0 in Q2 2021.
- The 3-year median for Income from Non-Controlling Interests is -$7000.0 (2021), against an average of -$11625.0.
- Peak annual rise in Income from Non-Controlling Interests reached 626.92% in 2022, while the deepest fall reached 143.49% in 2022.
- A 3-year view of Income from Non-Controlling Interests shows it stood at $26000.0 in 2021, then surged by 626.92% to $189000.0 in 2022, then tumbled by 224.34% to -$235000.0 in 2023.
- The last three Income from Non-Controlling Interests figures came in at -$235000.0 (Q1 2023), $189000.0 (Q4 2022), and -$40000.0 (Q3 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 100,000.00 |
| 10 | Cytek Biosciences | - | - | 21.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -235,000.00 |
| Dec 31, 2022 | 189,000.00 |
| Sep 30, 2022 | -40,000.00 |
| Jun 30, 2022 | 104,000.00 |
| Mar 31, 2022 | -137,000.00 |
| Dec 31, 2021 | 26,000.00 |
| Jun 30, 2021 | -315,000.00 |
| Mar 31, 2021 | 315,000.00 |